MIAMI, Sept 13 – Celera Genomics (NYSE:CRA) of Rockville, Md., said Wednesday that it had launched its Single-Nucleotide Polymorphism Reference Database for the human genome.

Celera’s first database release contains 2.8 million SNPs, including 2.4 million unique, proprietary SNPs taken from Celera’s human genome sequencing work, which decoded the genomes of five donors. The other 400,000 SNPs were culled from public databases.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.